Literature DB >> 12846564

Secondary structure in the nucleic acid affects the rate of HIV-1 nucleocapsid-mediated strand annealing.

Marie-Pierre Golinelli1, Stephen H Hughes.   

Abstract

We studied the effects of human immunodeficiency virus type 1 (HIV-1) nucleocapsid (NC) protein on the kinetics of annealing of nucleic acids using model substrates derived from the 3' end of the HIV-1 minus-strand strong-stop DNA (-sssDNA). We used HIV-1 reverse transcriptase (RT) to monitor the annealing reaction. Using several different DNA primers and acceptor oligonucleotides, we found that the rate of annealing increased with the size of the complementary region of the primer and the acceptor strands and decreased when secondary structures could be formed in either the primer or the acceptor strands. The secondary structure had a larger effect on the rate of annealing if the secondary structure extends to the 3' end of the nucleic acid(s). NC protein reduced the rate of annealing between strands with short homologies. NC had no major effect on the rate of annealing when there were at least 13 bases of complementarity between the primer and the acceptor strands and neither strand could form a stable secondary structure. NC increased the rate of annealing when the primer and/or the acceptor strand could form a secondary structure in the region of complementarity. When two strands were in competition as acceptors in an annealing reaction, the specificity of the annealing was determined by the length of the complementarity between the primer and the acceptor strands, the presence or the absence of secondary structures in the primer and/or the acceptor strand, and the presence or the absence of NC in the reaction. This suggests that NC facilitates strand transfer where the nucleic acids have considerable secondary structure (for example, the first strand transfers for viruses whose genomes have considerable secondary structure at their 3' ends). However, NC also appears to increase the fidelity of recombination by reducing strand transfers between segments that have limited complementarity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846564     DOI: 10.1021/bi027039w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.

Authors:  Sergiy V Avilov; Christian Boudier; Marina Gottikh; Jean-Luc Darlix; Yves Mély
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.

Authors:  Hsiao-Wei Liu; Gonzalo Cosa; Christy F Landes; Yining Zeng; Brandie J Kovaleski; Daniel G Mullen; George Barany; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

Review 3.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

4.  HIV-1 nucleocapsid protein switches the pathway of transactivation response element RNA/DNA annealing from loop-loop "kissing" to "zipper".

Authors:  My-Nuong Vo; George Barany; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Mol Biol       Date:  2009-01-06       Impact factor: 5.469

5.  Insights into the mechanisms of RNA secondary structure destabilization by the HIV-1 nucleocapsid protein.

Authors:  Anissa Belfetmi; Loussiné Zargarian; Carine Tisné; Dona Sleiman; Nelly Morellet; Ewen Lescop; Ouerdia Maskri; Brigitte René; Yves Mély; Philippe Fossé; Olivier Mauffret
Journal:  RNA       Date:  2016-01-29       Impact factor: 4.942

6.  Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.

Authors:  Tiyun Wu; Susan L Heilman-Miller; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2007-06-06       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.